Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Celanese (CE) EBT (2016 - 2025)

Celanese's EBT history spans 17 years, with the latest figure at $13.0 million for Q4 2025.

  • For Q4 2025, EBT rose 100.85% year-over-year to $13.0 million; the TTM value through Dec 2025 reached -$1.2 billion, down 19.94%, while the annual FY2025 figure was -$1.2 billion, 19.73% down from the prior year.
  • EBT reached $13.0 million in Q4 2025 per CE's latest filing, up from -$1.4 billion in the prior quarter.
  • In the past five years, EBT ranged from a high of $714.0 million in Q3 2023 to a low of -$1.5 billion in Q4 2024.
  • Average EBT over 5 years is $107.1 million, with a median of $180.0 million recorded in 2024.
  • Peak YoY movement for EBT: surged 348.98% in 2021, then crashed 1493.64% in 2024.
  • A 5-year view of EBT shows it stood at $622.0 million in 2021, then tumbled by 112.86% to -$80.0 million in 2022, then soared by 237.5% to $110.0 million in 2023, then plummeted by 1493.64% to -$1.5 billion in 2024, then skyrocketed by 100.85% to $13.0 million in 2025.
  • Per Business Quant, the three most recent readings for CE's EBT are $13.0 million (Q4 2025), -$1.4 billion (Q3 2025), and $135.0 million (Q2 2025).